RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert Onyenwoke to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications Robert Onyenwoke has written about Cystadenocarcinoma, Serous.
Robert Onyenwoke
Connection Strength
0.060
Cystadenocarcinoma, Serous
  1. Hanafi D, Onyenwoke RU, Kimbro KS. The G-Protein-Coupled Estrogen Receptor Selective Agonist G-1 Attenuates Cell Viability and Migration in High-Grade Serous Ovarian Cancer Cell Lines. Int J Mol Sci. 2024 Jun 13; 25(12).
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support